Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1989 | 09-1989 | 06-1989 | 03-1989 | 12-1988 | |
| Sales | 784,000 | 1,045,100 | 1,121,500 | 1,225,000 | 580,000 |
| Cost of Goods | 168,800 | 338,700 | 361,300 | 387,000 | 114,300 |
| Gross Profit | 615,200 | 706,400 | 760,200 | 838,000 | 716,500 |
| Operating Expenses | 404,700 | 455,900 | 459,500 | 436,700 | 351,700 |
| Operating Income | 211,300 | 251,200 | 301,000 | 401,300 | 114,300 |
| Other Income | 83,500 | 51,300 | 15,900 | 14,400 | 111,900 |
| Pre-tax Income | 294,800 | 302,500 | 316,900 | 415,700 | 226,200 |
| Income Tax | 69,500 | 90,100 | 99,800 | 131,000 | 50,500 |
| Net Income Continuous | 225,300 | 212,400 | 217,100 | 284,700 | 175,700 |
| Net Income | $225,300 | $212,400 | $217,100 | $284,700 | $175,700 |
| EPS Basic Total Ops | 0.20 | N/A | N/A | N/A | 0.16 |
| EPS Basic Continuous Ops | 0.20 | N/A | N/A | N/A | 0.16 |
| EPS Diluted Total Ops | 0.20 | N/A | N/A | N/A | 0.16 |
| EPS Diluted Continuous Ops | 0.20 | N/A | N/A | N/A | 0.16 |
| EBITDA(a) | $211,300 | $251,200 | $301,000 | $401,300 | $114,300 |